Effectiveness of disease-modifying agents in ameliorating multiple sclerosis – A cross-sectional observational study
Drug therapy is beneficial in providing remission and reducing relapse rates in MS. DMDs are effective in reducing the debilitating symptoms and preventing the progression of the disease, when begun immediately after the diagnosis is made.
Authors
- Sanitha Kuriachan (ORCID: https://orcid.org/0000-0002-2711-9816)
- Mamatha Jayachandran
- Dhanya Sacheendran (ORCID: https://orcid.org/0000-0002-2926-2296)
- Greeshma C. Ravindran (ORCID: https://orcid.org/0000-0001-5565-0498)
- Princy Louis Palatty (ORCID: https://orcid.org/0000-0003-4147-0482)
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
Publication Details
- Journal
- Indian Journal of Pharmacology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.4103/ijp.ijp_493_23
- Citations
- 1
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47